News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nucletron B.V. And RaySearch Laboratories Have Entered Into A Development And License Agreement Regarding Treatment Planning For Proton Therapy In Cancer Treatment


11/16/2006 11:41:12 AM

STOCKHOLM, Sweden--(BUSINESS WIRE)--RaySearch Laboratories AB (publ) and Nucletron BV are now initiating cooperation in treatment planning of proton radiation therapy of cancer. Today, the companies entered into a long-term development and license agreement that will result in a pioneering system for treatment planning and optimization of radiation therapy with protons. The new system, which is being built by RaySearch, will be integrated in Nucletron’s treatment planning system Oncentra™ MasterPlan.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES